Proteomic analysis of sequential isolates of multidrug-resistant Mycobacterium tuberculosis during treatment failure

J Infect. 2022 Nov;85(5):e137-e139. doi: 10.1016/j.jinf.2022.08.010. Epub 2022 Aug 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Mycobacterium tuberculosis*
  • Proteomics
  • Treatment Failure
  • Tuberculosis, Multidrug-Resistant* / drug therapy
  • Tuberculosis, Multidrug-Resistant* / microbiology

Substances

  • Antitubercular Agents